Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect

Eye

Volumn 23, Issue 2, 2009, Pages 290-293

  Chiang, C C ^a,b   Chen, W L ^a   Lin, J M ^a   Tsai, Y Y ^a  

^a CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Allogeneic serum; Autologous serum; Corneal epithelial defect; Dry eye

Indexed keywords

ALLOGENEIC SERUM; ARTIFICIAL TEAR; EPIDERMAL GROWTH FACTOR; EYE DROPS; RETINOL; TEARS NATURALE FREE; TRANSFORMING GROWTH FACTOR ALPHA; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; AMNION; ARTICLE; BLOOD; BLOOD ANALYSIS; BLOOD BANK; BLOOD TRANSFUSION; CHEMICAL INJURY; CLINICAL ARTICLE; CORNEA DISEASE; CORNEA EPITHELIUM; CORNEA ULCER; DILUTION; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; FAMILY; FOLLOW UP; GRAFT VERSUS HOST REACTION; HEALING; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INFORMED CONSENT; KERATOCONJUNCTIVITIS SICCA; KERATOPATHY; PATIENT COUNSELING; PENETRATING KERATOPLASTY; PERSISTENT CORNEAL EPITHELIAL DEFECT; SEROLOGY; SOFT CONTACT LENS; ULCER; BLOOD GROUP TYPING; CORNEAL DISEASES; EVALUATION STUDY; SERUM; TREATMENT OUTCOME; WOUND HEALING;

BLOOD GROUPING AND CROSSMATCHING; CORNEAL DISEASES; EPITHELIUM, CORNEAL; FOLLOW-UP STUDIES; HUMANS; KERATOPLASTY, PENETRATING; OPHTHALMIC SOLUTIONS; SERUM; TREATMENT OUTCOME; WOUND HEALING;

EID: 60149083079     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6703079     Document Type: Article

References (13)

1. Tsubota K, Goto E, Fujita H, Ono M, Inoue H, Saito I et al. Treatment of dry eye by autologous serum application in Sjogren's syndrome. Br J Ophthalmol 1999; 83: 390-395.
2. Matsumoto Y, Dogru M, Goto E, Ohashi Y, Kojima T, Ishida R et al. Autologous serum application in the treatment of neurotrophic keratopathy. Ophthalmology 2004; 111: 1115-1120.
3. Ogawa Y, Okamoto S, Mori T, Yamada M, Mashima Y, Watanbe R et al. Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease. Bone Marrow Transplant 2003; 31: 579-583.
4. van Setten GB, Viinikka L, Tervo T, Pesonen K, Tarkkanen A, Perheentupa J et al. Epidermal growth factor is a constant component of normal human tear fluid. Graefe's Arch Clin Exp Ophthalmol 1989; 227: 184-187.
5. Tsubota K, Goto E, Shimmura S, Shimazaki J. Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 1999; 106: 1984-1989.
6. Poon AC, Geerling G, Dart JK, Fraenkel GE, Daniels JT. Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies. Br J Ophthalmol 2001; 85: 1188-1197.
7. Fox RI, Chan R, Michelson J, Belmont JB, Michelson PE. Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca. Arthritis Rheum 1984; 29: 577-583.
8. Tseng SCG, Tsubota K. Important concepts for treating ocular surface and tear disorders. Am J Ophthalmol 1997; 124: 825-835.
9. Geerling G, Maclennan S, Hartwig D. Autologous serum eye drops for ocular surface disorders. Br J Ophthalmol 2004; 88: 1467-1474; review.
10. Young AL, Cheng AC, Ng HK, Cheng LL, Leung GY, Lam DS. The use of autologous serum tears in persistent corneal epithelial defects. Eye 2004; 18: 609-614.
11. Schulze SD, Sekundo W, Kroll P. Autologous serum for the treatment of corneal epithelial abrasions in diabetic patients undergoing vitrectomy. Am J Ophthalmol 2006; 142: 207-211.
12. Blanco AA, Pillai CT, Dua HS. Amniotic membrane transplantation for ocular surface reconstruction. Br J Ophthalmol 1999; 83: 399-402.
13. Vajpayee RB, Mukerji N, Tandon R, Sharma N, Pandey RM, Biswas NR et al. Evaluation of umbilical cord serum therapy for persistent corneal epithelial defects. Br J Ophthalmol 2003; 87: 1312-1316.